So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| AddiQoL: Thang đo Chất lượng Cuộc sống trong Suy thượng thận× | AGHDA: Đánh giá Thiếu hụt Hormone Tăng trưởng ở Người trưởng thành× | |
|---|---|---|
| Lĩnh vực | Nội tiết học | Nội tiết học |
| Họ | Process / pipeline | Process / pipeline |
| Năm ra đời≠ | 2012 | 2000 |
| Người khởi xướng≠ | Adriana Evers, Jeanieke Tiemensma | Anthony Hunt, Garry Werther, Peter Wrightson |
| Loại | Patient self-report questionnaire | Patient self-report questionnaire |
| Công trình gốc≠ | Evers, A. C., & Tiemensma, J. (2012). AddiQoL: A disease-specific quality of life scale for patients with primary adrenal insufficiency. J Clin Endocrinol Metab, 97(10), 3501-3508. link ↗ | Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346. link ↗ |
| Tên gọi khác≠ | Addison Quality of Life, AI-QoL | AGHDA-25 |
| Liên quan | 3 | 3 |
| Tóm tắt≠ | AddiQoL is a disease-specific quality of life questionnaire developed to assess the burden of primary and secondary adrenal insufficiency, encompassing physical, emotional, and social domains relevant to patients on glucocorticoid and mineralocorticoid replacement therapy. Developed by Evers and Tiemensma in 2012, it is the first formally validated instrument specifically designed for adrenal insufficiency populations. | The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy. |
| ScholarGateBộ dữ liệu ↗ |
|
|